Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Sandow
J. Sandow
Hammersmith Hospital
Prostate cancer
Medicine
Buserelin
Urology
Cancer
4
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Three-monthly GnRH agonist (buserelin) for prostatic cancer.
1990
BJUI
J. Waxman
J. Sandow
P. D. Abel
C. Barton
P. F. Keane
G. Williams
Show All
Source
Cite
Save
Citations (8)
Two-monthly depot gonadotropin releasing hormone agonist (buserelin) for treatment of prostatic cancer
1989
European Journal of Endocrinology
J. Waxman
J. Sandow
P. D. Abel
N. Farah
E. P. N. O'donoghue
J Fleming
J Cox
Karol Sikora
Gordon Williams
Show All
Source
Cite
Save
Citations (14)
A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer
1989
Cancer Chemotherapy and Pharmacology
J. Waxman
J. Sandow
H. Thomas
N. James
G. Williams
Show All
Source
Cite
Save
Citations (6)
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
1988
American Journal of Clinical Oncology
Jonathan Waxman
Gordon Williams
J. Sandow
Hewitt G
P. D. Abel
N. Farah
J Fleming
J Cox
E. P. N. O'donoghue
Karol Sikora
Show All
Source
Cite
Save
Citations (9)
1